Methodological approaches and insights on protein aggregation in biological systems

References

• Tyedmers J, Mogk A, Bukau B. Cellular strategies for controlling protein aggregation. Nat Rev Mol Cell Biol. 2010;11(11):777–788.
   PubMed Web of Science ®Google Scholar
• King J, Haase-Pettingell C, Gossard D. Protein folding and misfolding. Am Sci. 2002;90(5):445–453.
   Web of Science ®Google Scholar
• Gebbink MFBG, Bouma B, Maas C, et al. Physiological responses to protein aggregates: fibrinolysis, coagulation and inflammation (new roles for old factors). FEBS Lett. 2009;583(16):2691–2699.
   PubMed Web of Science ®Google Scholar
• Jahn TR, Radford SE. The Yin and Yang of protein folding. Febs J. 2005;272(23):5962–5970.
   PubMed Web of Science ®Google Scholar
• Ausar S. Forced degradation studies: an essential tool for the formulation development of vaccines. Vaccine Dev Ther. 2013;3:11–33.
   Google Scholar
• Reis-Rodrigues P, Czerwieniec G, Peters TW, et al. Proteomic analysis of age-dependent changes in protein solubility identifies genes that modulate lifespan. Aging Cell. 2012;11(1):120–127.
   PubMed Web of Science ®Google Scholar
• Mirzaei H, Protein: RF. protein aggregation induced by protein oxidation. J Chromatogr B Anal Technol Biomed Life Sci. 2008;873(1):8–14.
   PubMed Web of Science ®Google Scholar
• Shacter E. Quantification and significance of protein oxidation in biological samples. Drug Metab Rev. 2000;32(3–4):307–326.
   PubMed Web of Science ®Google Scholar
• Ey C, Weickmann J, Jf C, et al. Heterogeneous nucleation-controlled particulate formation of recombinant human platelet-activating factor acetylhydrolase in pharmaceutical formulation. J Pharm Sci. 2005;94(2):256–274.
   PubMed Web of Science ®Google Scholar
• Jones LS, Kaufmann A, Middaugh CR. Silicone oil induced aggregation of proteins. J Pharm Sci. 2005;94(4):918–927.
   PubMed Web of Science ®Google Scholar
• Woods AS, Ferre S. Amazing stability of the arginine-phosphate electrostatic interaction. J Proteome Res. 2005;4(4):1397–1402.
   PubMed Web of Science ®Google Scholar
• Kitchen J, Saunders RE, Warwicker J. Charge environments around phosphorylation sites in proteins. BMC Struct Biol. 2008;8:19.
   PubMed Web of Science ®Google Scholar
• Ben-Nissan G, Sharon M. Regulating the 20S Proteasome Ubiquitin-Independent Degradation Pathway. Biomolecules. 2014;4(3):862–884.
   PubMedGoogle Scholar
• Arrasate M, Finkbeiner S. Protein aggregates in Huntington’s disease. Exp Neurol. 2012;238(1):1–11.
   PubMed Web of Science ®Google Scholar
• Weiss MA. Diabetes mellitus due to the toxic misfolding of proinsulin variants. FEBS Lett. 2013;587(13):1942–1950.
   PubMed Web of Science ®Google Scholar
• Jensen TJ, Loo MA, Pind S, et al. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell. 1995;83(1):129–135.
   PubMed Web of Science ®Google Scholar
• Munishkina LA, Cooper EM, Uversky VN, et al. The effect of macromolecular crowding on protein aggregation and amyloid fibril formation. J Mol Recognit. 2004;17:456–464.
   PubMed Web of Science ®Google Scholar
• Beyer K, Ariza A. Protein aggregation mechanisms in synucleinopathies: commonalities and differences. J Neuropathol Exp Neurol. 2007;66(11):965–974.
   PubMed Web of Science ®Google Scholar
• Bartolini M, Bertucci C, Bolognesi ML, et al. Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: Elucidation of inhibitors’ mechanism of action. ChemBioChem. 2007;8(17):2152–2161.
   PubMed Web of Science ®Google Scholar
• Fezoui Y, Teplow DB. Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization. J Biol Chem. 2002;277(40):36948–36954.
   PubMed Web of Science ®Google Scholar
• Necula M, Kayed R, Milton S, et al. Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem. 2007;282(14):10311–10324.
   PubMed Web of Science ®Google Scholar
• Huang THJ, Yang DS, Fraser PE, et al. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide: an in vitro model of preamyloid. J Biol Chem. 2000;275(46):36436–36440.
   PubMed Web of Science ®Google Scholar
• Weber B, Schaper C, J S, et al. Interaction of the amyloid precursor like protein 1 with the alpha2A-adrenergic receptor increases agonist-mediated inhibition of adenylate cyclase. Cell Signal. 2006;18(10):1748–1757.
   PubMed Web of Science ®Google Scholar
• Scruggs SB, Zong NC, Wang D, et al. Post-translational modification of cardiac proteasomes: functional delineation enabled by proteomics. AJP Hear Circ Physiol. 2012;303(1):H9–H18.
   PubMedGoogle Scholar
• Wang X, Pattison JS, Su H. Posttranslational modification and quality control. Circ Res. 2013;112(2):367–381.
   PubMed Web of Science ®Google Scholar
• Stadtman ER, Levine RL. Protein oxidation. Ann N Y Acad Sci. 2000;899(1):191–208.
   PubMed Web of Science ®Google Scholar
• Friguet B, Szweda LI, Stadtman ER. Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease. Arch Biochem Biophys. 1994;311(1):168–173.
   PubMed Web of Science ®Google Scholar
• Bulteau AL, Lundberg KC, Humphries KM, et al. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem. 2001;276(32):30057–30063.
   PubMed Web of Science ®Google Scholar
• Predmore JM, Wang P, Davis F, et al. Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies. Circulation. 2010;121(8):997–1004.
   PubMed Web of Science ®Google Scholar
• Papa L, Gomes E, Rockwell P. Reactive oxygen species induced by proteasome inhibition in neuronal cells mediate mitochondrial dysfunction and a caspase-independent cell death. Apoptosis. 2007;12(8):1389–1405.
   PubMed Web of Science ®Google Scholar
• Fiori J, Naldi M, Bartolini M, et al. Disclosure of a fundamental clue for the elucidation of the myricetin mechanism of action as amyloid aggregation inhibitor by mass spectrometry. Electrophoresis. 2012;33(22):3380–3386.
   PubMed Web of Science ®Google Scholar
• Zhang YW, Otterness DM, Chiang GG, et al. Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. Mol Cell. 2005;19(5):607–618.
   PubMed Web of Science ®Google Scholar
• Drews O, Tsukamoto O, Liem D, et al. Differential regulation of proteasome function in isoproterenol-induced cardiac hypertrophy. Circ Res. 2010;107(9):1094–1101.
   PubMed Web of Science ®Google Scholar
• Bingol B, Wang CF, Arnott D, et al. Autophosphorylated CaMKII alpha acts as a scaffold to recruit proteasomes to dendritic spines. Cell. 2010;140(4):567–578.
   PubMed Web of Science ®Google Scholar
• Scroggins BT, Robzyk K, Wang D, et al. An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol Cell. 2007;25(1):151–159.
   PubMed Web of Science ®Google Scholar
• Kovacs JJ, Murphy PJM, Gaillard S, et al. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol Cell. 2005;18(5):601–607.
   PubMed Web of Science ®Google Scholar
• Ogiso H, Kagi N, Matsumoto E, et al. Phosphorylation analysis of 90 kDa heat shock protein within the cytosolic arylhydrocarbon receptor complex. Biochemistry. 2004;43(49):15510–15519.
   PubMed Web of Science ®Google Scholar
• Yang W-L, Wang J, Chan C-H, et al. The E3 Ligase TRAF6 Regulates Akt Ubiquitination and Activation. Sci. 2009;325(5944):1134–1138.
   PubMed Web of Science ®Google Scholar
• Ravid T, Hochstrasser M. Diversity of degradation signals in the ubiquitin-proteasome system. Nat Rev Mol Cell Biol. 2008;9(9):679–690.
   PubMed Web of Science ®Google Scholar
• Sarikas A, Hartmann T, Pan Z-Q. The cullin protein family. Genome Biol. 2011;12(4):220.
   PubMed Web of Science ®Google Scholar
• Chen Z, Sui J, Zhang F, et al. Cullin family proteins and tumorigenesis: Genetic association and molecular mechanisms. J Cancer. 2015;6(3):233–242.
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature. 2006;443(7113):780–786.
   PubMed Web of Science ®Google Scholar
• He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 2009;43:67–93.
   PubMed Web of Science ®Google Scholar
• Halperin L, Jung J, Michalak M. The many functions of the endoplasmic reticulum chaperones and folding enzymes. IUBMB Life. 2014;66(5):318–326.
   PubMed Web of Science ®Google Scholar
• Labbadia J, Morimoto RI. The biology of proteostasis in aging and disease. Annu Rev Biochem. 2015;84(1):435–464.
   PubMed Web of Science ®Google Scholar
• Chen B, Piel WH, Gui L, et al. The HSP90 family of genes in the human genome: insights into their divergence and evolution. Genomics. 2005;86(6):627–637.
   PubMed Web of Science ®Google Scholar
• Schild H, Rammensee HG. gp96–the immune system’s Swiss army knife. Nat Immunol. 2000;1(2):100–101.
   PubMed Web of Science ®Google Scholar
• Meusser B, Hirsch C, Jarosch E, et al. ERAD: the long road to destruction. Nat Cell Biol. 2005;7(8):766–772.
   PubMed Web of Science ®Google Scholar
• Carra S, Seguin SJ, Landry J. HspB8 and Bag3: a new chaperone complex targeting misfolded proteins to macroautophagy. Autophagy. 2008;4(2):237–239.
   PubMed Web of Science ®Google Scholar
• Gamerdinger M, Kaya AM, Wolfrum U, et al. BAG3 mediates chaperone-based aggresome-targeting and selective autophagy of misfolded proteins. EMBO Rep [Internet]. 2011;12(2):149 LP–156. Available from http://embor.embopress.org/content/12/2/149.abstract
   Google Scholar
• Behl C. BAG3 and friends: Co-chaperones in selective autophagy during aging and disease. Autophagy[Internet]. 2011;7(7):795–798. Available from http://dx.doi.org/10.4161/auto.7.7.15844
   PubMed Web of Science ®Google Scholar
• Ngo JK, Davies KJA. Mitochondrial Lon protease is a human stress protein. Free Radic Biol Med. 2009;46(8):1042–1048.
   PubMed Web of Science ®Google Scholar
• Horwich AL. Fenton W A, Chapman E, Farr GW. Two families of chaperonin: physiology and mechanism. Annu Rev Cell Dev Biol. 2007;23:115–145.
   PubMed Web of Science ®Google Scholar
• Bukau B, Weissman J, Horwich A. Molecular Chaperones and Protein Quality Control. Cell. 2006;125(3):443–451.
   PubMed Web of Science ®Google Scholar
• Nishida K, Otsu K. Autophagy during cardiac remodeling. J Mol Cell Cardiol. 2016;95:11-18.
   Web of Science ®Google Scholar
• Batulan Z, Pulakazhi Venu VK, Li Y, et al. Extracellular release and signaling by heat shock protein 27: Role in modifying vascular inflammation. Front Immunol. 2016;7:285.
   PubMed Web of Science ®Google Scholar
• Sultan A, Raman B, Rao CM, et al. The extracellular chaperone haptoglobin prevents serum fatty acid-promoted amyloid fibril formation of β2-microglobulin, resistance to lysosomal degradation, and cytotoxicity. J Biol Chem. 2013;288(45):32326–32342.
   PubMed Web of Science ®Google Scholar
• Kranenburg O, Bouma B, Kroon-Batenburg LMJ, et al. Tissue-type plasminogen activator is a multiligand cross-beta structure receptor. Curr Biol. 2002;12(2):1833–1839.
   PubMed Web of Science ®Google Scholar
• Maas C, Govers-Riemslag JWP, Bouma B, et al. Misfolded proteins activate Factor XII in humans, leading to kallikrein formation without initiating coagulation. J Clin Invest. 2008;118(9):3208–3218.
   PubMed Web of Science ®Google Scholar
• Maas C, Schiks B, Strangi RD, et al. Identification of fibronectin type I domains as amyloid-binding modules on tissue-type plasminogen activator and three homologs. Amyloid. 2008;15(3):166–180.
   PubMed Web of Science ®Google Scholar
• Schenck JF. Safety of strong, static magnetic fields. J Magn Reson Imaging. 2000;12(1):2–19.
   PubMed Web of Science ®Google Scholar
• Chao J, Bledsoe G, Yin H, et al. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction. Biol Chem. 2006;387(6):665-675.
   Web of Science ®Google Scholar
• Demontis F, Perrimon N. FOXO/4E-BP signaling in Drosophila muscles regulates organism-wide proteostasis during aging. Cell. 2010;143(5):813–825.
   PubMed Web of Science ®Google Scholar
• Askanas V, Engel WK, Nogalska A. Inclusion body myositis: A degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation: mini-symposium: protein aggregate myopathies. Brain Pathology. 2009;19:493–506.
   PubMed Web of Science ®Google Scholar
• Beyreuther K, Bush AI, Dyrks T, et al. Mechanisms of amyloid deposition in Alzheimer’s disease. Ann N Y Acad Sci. 1991;640:129–139.
   PubMed Web of Science ®Google Scholar
• Herskowitz JH, Feng Y, Mattheyses AL, et al. Pharmacologic inhibition of ROCK2 suppresses amyloid-β production in an Alzheimer’s disease mouse model. J Neurosci. 2013;33(49):19086–19098.
   PubMed Web of Science ®Google Scholar
• Kummer MP, Heneka MT. Truncated and modified amyloid-beta species. Alzheimers Res Ther. 2014;6(3):28.
   PubMed Web of Science ®Google Scholar
• Geschwind DH. Tau phosphorylation, tangles, and neurodegeneration: The chicken or the egg? Neuron. 2003;40(3):457–460.
   PubMed Web of Science ®Google Scholar
• Cohen TJ, Friedmann D, Hwang AW, et al. The microtubule-associated tau protein has intrinsic acetyltransferase activity. Nat Struct Mol Biol. 2013;20(6):756–762.
   PubMed Web of Science ®Google Scholar
• Cook C, Carlomagno Y, Gendron TF, et al. Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance. Hum Mol Genet. 2014;23(1):104–116.
   PubMed Web of Science ®Google Scholar
• Fujiwara H, Hasegawa M, Dohmae N, et al. α-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol. 2002;4(2):160–164.
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Fujiwara H, Nonaka T, et al. Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. J Biol Chem. 2002;277(50):49071–49076.
   PubMed Web of Science ®Google Scholar
• Um JW, Han KA, Im E, et al. Neddylation positively regulates the ubiquitin E3 ligase activity of parkin. J Neurosci Res. 2012;90(5):1030–1042.
   PubMed Web of Science ®Google Scholar
• Chung KKK, Thomas B, Li X, et al. S-nitrosylation of parkin regulates ubiquitination and compromises parkin’s protective function. Science. 2004;304(5675):1328–1331.
   PubMed Web of Science ®Google Scholar
• Dammer EB, Fallini C, Gozal YM, et al. Coaggregation of RNA-binding proteins in a model of TDP-43 proteinopathy with selective RGG motif methylation and a role for RRM1 ubiquitination. Plos One. 2012;7:6.
   Web of Science ®Google Scholar
• Cohen TJ, Hwang AW, Unger T, et al. Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking. Embo J. 2012;31(5):1241–1252.
   PubMed Web of Science ®Google Scholar
• Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130–133.
   PubMed Web of Science ®Google Scholar
• Willis M, Patterson C. Proteotoxicity and cardiac dysfunction — alzheimer’s disease of the heart? N Engl J Med. 2013;368(5):455–464.
   PubMed Web of Science ®Google Scholar
• Shih H, Lee B, Lee RJ, et al. The aging heart and post-infarction left ventricular remodeling. J Am Coll Cardiol. 2010;57(1):9–17.
   Web of Science ®Google Scholar
• Tannous P, Zhu H, Nemchenko A, et al. Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy. Circulation. 2008;117(24):3070–3078.
   PubMed Web of Science ®Google Scholar
• Ayyadevara S, Mercanti F, Wang X, et al. Age- and hypertension-associated protein aggregates in mouse heart have similar proteomic profiles. Hypertension. 2016;67(5):1006–1013.
   PubMed Web of Science ®Google Scholar
• Su H, Li J, Menon S, et al. Perturbation of cullin deneddylation via conditional Csn8 ablation impairs the ubiquitin-proteasome system and causes cardiomyocyte necrosis and dilated cardiomyopathy in mice. Circ Res. 2011;108(1):40–50.
   PubMed Web of Science ®Google Scholar
• Agnetti G, Halperin VL, Kirk JA, et al. Desmin modifications associate with amyloid-like oligomers deposition in heart failure. Cardiovasc Res. 2014;102(1):24–34.
   PubMed Web of Science ®Google Scholar
• Del Monte F, Agnetti G. Protein post-translational modifications and misfolding: new concepts in heart failure. Proteomics Clin Appl. 2014;8(7–8):534–542.
   PubMed Web of Science ®Google Scholar
• Zhu H, Sun X, Wang D, et al. Doxycycline ameliorates aggregation of collagen and atrial natriuretic peptide in murine post-infarction heart. Eur J Pharmacol. 2015;754:66–72.
   PubMed Web of Science ®Google Scholar
• McLendon PM, Ferguson BS, Osinska H, et al. Tubulin hyperacetylation is adaptive in cardiac proteotoxicity by promoting autophagy. Proc Natl Acad Sci U S A. 2014;111(48):E5178–86.
   PubMedGoogle Scholar
• Harper JD, Lieber CM, Lansbury PT Jr. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer’s disease amyloid-beta protein. Chem Biol. 1997;4(12):951–959.
   PubMedGoogle Scholar
• Langkilde AE, Morris KL, Serpell LC, et al. The architecture of amyloid-like peptide fibrils revealed by X-ray scattering, diffraction and electron microscopy. Acta Crystallogr Sect D Biol Crystallogr. 2015;71:882–895.
   PubMedGoogle Scholar
• Pai AS, Rubinstein I, Önyüksel H. PEGylated phospholipid nanomicelles interact with β-amyloid(1-42) and mitigate its β-sheet formation, aggregation and neurotoxicity in vitro. Peptides. 2006;27(11):2858–2866.
   PubMed Web of Science ®Google Scholar
• Nichols MR, Moss MA, Reed DK, et al. Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology. J Biol Chem. 2005;280(4):2471–2480.
   PubMed Web of Science ®Google Scholar
• Parenky A, Myler H, Amaravadi L, et al. New FDA draft guidance on immunogenicity. Aaps J. 2014;16(3):499–503.
   PubMed Web of Science ®Google Scholar
• Hermeling S, Crommelin DJA, Schellekens H, et al. Structure-immunogenicity relationships of therapeutic proteins. Pharm Res. 2004;21(6):897–903.
   PubMed Web of Science ®Google Scholar
• Rosenberg AS. Effects of protein aggregates: an immunologic perspective. Aaps J. 2006;8(3):E501–E507.
   PubMed Web of Science ®Google Scholar
• Philo JS. A critical review of methods for size characterization of non-particulate protein aggregates. Curr Pharm Biotechnol. 2009;10(4):359–372.
   PubMed Web of Science ®Google Scholar
• Teraoka I. Calibration of retention volume in size exclusion chromatograpny by hydrodynamic radius. Macromolecules. 2004;37(17):6632–6639.
   Web of Science ®Google Scholar
• Horneman DA, Ottens M, Keurentjes JTF, van der Wielen LAM. Surfactant-aided size-exclusion chromatography for the purification of immunoglobulin G. J Chromatogr A. 2007;1157(1–2):237–245.
   PubMed Web of Science ®Google Scholar
• Huang CT, Sharma D, Oma P, et al. Quantitation of protein particles in parenteral solutions using micro-flow imaging. J Pharm Sci. 2009;98(9):3058–3071.
   PubMed Web of Science ®Google Scholar
• Sharma KD, Peter O, Pollo MJ, et al. Quantification and characterization of subvisible proteinaceous particles in opalescent mab formulations using micro-flow imaging. J Pharm Sci. 2010;99(6):2628–2642.
   PubMed Web of Science ®Google Scholar
• Zambrano R, Jamroz M, Szczasiuk A, et al. AGGRESCAN3D (A3D): server for prediction of aggregation properties of protein structures. Nucleic Acids Res. 2015;43(W1):W306-313.
   Web of Science ®Google Scholar
• Walther DM, Kasturi P, Zheng M, et al. Widespread proteome remodeling and aggregation in aging C. elegans. Cell. 2015;161(4):919–932.
   PubMed Web of Science ®Google Scholar
• David DC, Ollikainen N, Trinidad JC, et al. Widespread protein aggregation as an inherent part of aging in C. elegans. Plos Biol. 2010;8(8):e1000450.
   PubMed Web of Science ®Google Scholar
• Bindea G, Mlecnik B, Hackl H, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25(8):1091–1093.
   PubMed Web of Science ®Google Scholar
• Niwa T, Ying B-W, Saito K, et al. Bimodal protein solubility distribution revealed by an aggregation analysis of the entire ensemble of Escherichia coli proteins. Proc Natl Acad Sci U S A. 2009;106(11):4201–4206.
   PubMed Web of Science ®Google Scholar
• Geerlof A, Brown J, Coutard B, et al. The impact of protein characterization in structural proteomics. Acta Crystallogr Sect D Biol Crystallogr. 2006;62(10):1125–1136.
   PubMedGoogle Scholar
• Jacobsen NE. NMR spectroscopy explained: simplified theory, applications and examples for organic chemistry and structural biology. Wiley 2007; ISBN: 978-0-471-73096-5.
   Google Scholar
• Lu J-X, Qiang W, Yau W-M, et al. Molecular structure of β-amyloid fibrils in Alzheimer’s disease brain tissue. Cell. 2013;154(6):1257–1268.
   PubMed Web of Science ®Google Scholar
• Beveridge R, Chappuis Q, Macphee C, et al. Mass spectrometry methods for intrinsically disordered proteins. Analyst. 2013;138:32–42.
   PubMed Web of Science ®Google Scholar
• Carulla N, Zhou M, Arimon M, et al. Experimental characterization of disordered and ordered aggregates populated during the process of amyloid fibril formation. Proc Natl Acad Sci U S A. 2009;106(19):7828–7833.
   PubMed Web of Science ®Google Scholar
• Lu X, Wintrode PL, Surewicz WK. Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange. Proc Natl Acad Sci U S A. 2007;104(5):1510–1515.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Smith DL. Determination of amide hydrogen exchange by mass spectrometry: a new tool for protein structure elucidation. Protein Sci. 1993;2(4):522–531.
   PubMed Web of Science ®Google Scholar
• Bronsoms S, Trejo SA. Applications of mass spectrometry to the study of protein aggregation. Methods Mol Biol. 2015;1258:331–345.
   PubMedGoogle Scholar
• Marcoux J, Thierry E, Vivès C, et al. Investigating alternative acidic proteases for H/D exchange coupled to mass spectrometry: plasmepsin 2 but not plasmepsin 4 is active under quenching conditions. J Am Soc Mass Spectrom. 2010;21(1):76–79.
   PubMed Web of Science ®Google Scholar
• Cravello L, Lascoux D, Forest E. Use of different proteases working in acidic conditions to improve sequence coverage and resolution in hydrogen/deuterium exchange of large proteins. Rapid Commun Mass Spectrom. 2003;17(21):2387–2393.
   PubMed Web of Science ®Google Scholar
• Qi W, Zhang A, Patel D, et al. Simultaneous monitoring of peptide aggregate distributions, structure, and kinetics using amide hydrogen exchange: application to abeta (1-40) fibrillogenesis. Biotechnol Bioeng. 2008;100(6):1214–1227.
   PubMed Web of Science ®Google Scholar
• Arunkumar AI, Kumar TKS, Sivaraman T, et al. Acetonitrile-induced conformational transitions in poly-L-lysine. Int J Biol Macromol. 1997;21(4):299–305.
   PubMed Web of Science ®Google Scholar
• Bartolini M, Bertucci C, Cavrini V, et al. Beta-Amyloid aggregation induced by human acetylcholinesterase: Inhibition studies. Biochem Pharmacol. 2003;65(3):407–416.
   PubMed Web of Science ®Google Scholar
• Fezoui Y, Hartley DM, Harper JD, et al. An improved method of preparing the amyloid b-protein for fibrillogenesis and neurotoxicity experiments. Amyloid Int J Exp Clin Investig. 2000;7(3):166–178.
   PubMed Web of Science ®Google Scholar
• Tomaselli S, Esposito V, Vangone P, et al. The alpha-to-beta conformational transition of Alzheimer’s Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding. Chembiochem. 2006;7(2):257–267.
   PubMed Web of Science ®Google Scholar
• Wang G, Johnson AJ, Kaltashov IA. Evaluation of electrospray ionization mass spectrometry as a tool for characterization of small soluble protein aggregates. Anal Chem. 2012;84(3):1718–1724.
   PubMed Web of Science ®Google Scholar
• Muneeruddin K, Thomas JJ, Salinas PA, et al. Characterization of small protein aggregates and oligomers using size exclusion chromatography with online detection by native electrospray ionization mass spectrometry. Anal Chem. 2014;86(21):10692–10699.
   PubMed Web of Science ®Google Scholar
• Bobst CE, Thomas JJ, Salinas PA, et al. Impact of oxidation on protein therapeutics: Conformational dynamics of intact and oxidized acid-beta-glucocerebrosidase at near-physiological pH. Protein Sci. 2010;19(12):2366–2378.
   PubMed Web of Science ®Google Scholar
• Zovo K, Helk E, Karafin A, et al. Label-free high-throughput screening assay for inhibitors of Alzheimer’s amyloid-β peptide aggregation based on MALDI MS. Anal Chem. 2010;82(20):8558–8565.
   PubMed Web of Science ®Google Scholar
• Kelly SMMM, Price NCCC. The use of circular dichroism in the investigation of protein structure and function. Curr Protein Pept Sci. 2000;1(4):349–384.
   PubMed Web of Science ®Google Scholar
• Hu L, Olsen C, Maddux N, et al. Investigation of protein conformational stability employing a multimodal spectrometer. Anal Chem. 2011;83(24):9399–9405.
   PubMed Web of Science ®Google Scholar
• Garcia-Alloza M, Dodwell SA, Meyer-Luehmann M, et al. Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model. J Neuropathol Exp Neurol. 2006;65(11):1082–1089.
   PubMed Web of Science ®Google Scholar
• Ben-Zvi A, Miller EA, Morimoto RI. Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc Natl Acad Sci U S. 2009;106(35):14914–14919.
   PubMed Web of Science ®Google Scholar
• Zid BM, Rogers AN, Katewa SD, et al. 4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in drosophila. Cell. 2009;139(1):149–160.
   PubMed Web of Science ®Google Scholar
• Tonoki A, Kuranaga E, Tomioka T, et al. Genetic evidence linking age-dependent attenuation of the 26S proteasome with the aging process. Mol Cell Biol. 2009;29(4):1095–1106.
   PubMed Web of Science ®Google Scholar
• Yang DS, Stavrides P, Mohan PS, et al. Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis. Autophagy. 2011;7(7):788–789.
   PubMed Web of Science ®Google Scholar
• Cohen E, Bieschke J, Perciavalle RM, et al. Opposing activities protect against age-onset proteotoxicity. Science. 2006;313(5793):1604–1610.
   PubMed Web of Science ®Google Scholar
• Morley JF, Brignull HR, Weyers JJ, et al. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2002;99(16):10417–10422.
   PubMed Web of Science ®Google Scholar
• Coughlan CM, Brodsky JL. Use of yeast as a model system to investigate protein conformational diseases. Mol Biotechnol. 2005;30(2):171–180.
   PubMed Web of Science ®Google Scholar
• Kaganovich D, Kopito R, Frydman J. Misfolded proteins partition between two distinct quality control compartments. Nature. 2008;454(7208):1088–1095.
   PubMed Web of Science ®Google Scholar
• Johnston JA, Ward CL, Kopito RR. Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 1998;143(7):1883–1898.
   PubMed Web of Science ®Google Scholar
• Boyault C, Zhang Y, Fritah S, et al. HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. Genes Dev. 2007;21(17):2172–2181.
   PubMed Web of Science ®Google Scholar
• Olzmann JA, Li A, Chudaev MV, et al. Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6. J. Cell Biol. 2007;178(6):1025–1038.
   PubMed Web of Science ®Google Scholar
• Hamer G, Matilainen O, Holmberg CI. A photoconvertible reporter of the ubiquitin-proteasome system in vivo. Nat Methods. 2010;7(6):473–478.
   PubMed Web of Science ®Google Scholar
• Kern A, Ackermann B, Clement AM, et al. HSF1-controlled and age-associated chaperone capacity in neurons and muscle cells of C. elegans. Plos One. 2010;5(1):e8568.
   Web of Science ®Google Scholar
• Bieler S, Soto C. Beta-sheet breakers for Alzheimer’s disease therapy. Curr Drug Targets. 2004;5(6):553–558.
   PubMed Web of Science ®Google Scholar
• Soto C, Estrada L. Amyloid inhibitors and beta-sheet breakers. Subcell Biochem. 2005;38:351–364.
   PubMedGoogle Scholar
• Deshpande A, Mina E, Glabe C, et al. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci Off J Soc Neurosci. 2006;26(22):6011–6018.
   PubMed Web of Science ®Google Scholar
• Lin HAI, Bhatia R, Lal R. Amyloid β protein forms ion channels: implications for Alzheimer’s disease pathophysiology. Faseb J. 2001;15(13):2433–2444.
   PubMed Web of Science ®Google Scholar
• Nyström T. Role of oxidative carbonylation in protein quality control and senescence. Embo J. 2005;24(7):1311–1317.
   PubMed Web of Science ®Google Scholar
• Maharjan S, Oku M, Tsuda M, et al. Mitochondrial impairment triggers cytosolic oxidative stress and cell death following proteasome inhibition. Sci Rep. 2014;4:5896.
   PubMed Web of Science ®Google Scholar
• Ott C, Jacobs K, Haucke E, et al. Role of advanced glycation end products in cellular signaling. Redox Biol. 2014;2(1):411–429.
   PubMed Web of Science ®Google Scholar
• Gasic-Milenkovic J, Loske C, Munch G. Advanced glycation endproducts cause lipid peroxidation in the human neuronal cell line SH-SY5Y. J Alzheimers Dis. 2003;5:25–30.
   PubMed Web of Science ®Google Scholar
• Gella A, Durany N. Oxidative stress in Alzheimer disease. Cell Adh Migr. 2009;3(1):88–93.
   PubMed Web of Science ®Google Scholar
• Xue L, Rup B. Evaluation of pre-existing antibody presence as a risk factor for posttreatment anti-drug antibody induction: analysis of human clinical study data for multiple biotherapeutics. Aaps J. 2013;15(3):893–896.
   PubMed Web of Science ®Google Scholar